Ozempic is officially authorised and licensed in the UK, but only for treating type 2 diabetes
PMC 2983067
Safety Profile of BPC-157 Studies suggest that BPC-157 peptide therapy is safe and well-tolerated when used correctly
A 2023 case series published in the Journal of Clinical Psychopharmacology reported on six patients with BED treated with semaglutide, five of whom experienced substantial reductions in binge frequency and loss of control eating
Following the injection, imaging was performed using an IVIS Spectrum system (PerkinElmer) at various time points: 1 h, 4 h, 7 h, 12 h, 24 h, 36 h, 48 h, and 60 h post-injection, with an excitation wavelength of 780 nm and a fluorescence emission wavelength of 840 nm
10.3390/ijms24108917 24 GomaaM